Professional development Vacancies

IPA training on quality and inspections in Amsterdam (Netherlands), June 2023

17.10.2023 Updated 10.01.2024 1137 views

Representatives of the Center Nadiia DOROTIUK, expert of the Division for Expert Evaluation of Bioavailability and Bioequivalence Materials, Olha KOLESOVA, expert of the Department of Expert Evaluation of Registration Materials, and Petro HOLODIUK, together with experts of the MoH and the State Service of Ukraine on Medicines and Drugs Control, completed the EMA advanced training course on quality and inspections. In addition, more than 15 specialists of the Center attended the seminar online.

As part of the program, the experts strengthened their professional competencies at the following seminars:

  • Quality defects and recalls: detailed EU procedures and practice. Moderators: Tom Brusselmans (EMA), Patricia Nagtegaal and Niels Speksnijder (Health and Youth Care Inspectorate, the Netherlands)
  • Live biotherapeutic products: regulatory requirements. Moderators: Katrin Briuss (Federal Institute for Drugs and Medical Devices (BfArM) – Germany)
  • Good Distribution Practice (GDP). Moderator: Barbara Henry (Health Products Regulatory Authority (HPRA) – Ireland)
  • Sampling and testing. Good Manufacturing Practice (GMP). Moderator: Ruben Lindo (EMA)

The goal of participation in the training is a detailed familiarization with the functioning of the EU medicines regulatory system: procedures for quality assessment, good manufacturing practice (GMP), and good distribution practice (GDP).

Over the two days of training, our experts were able to deepen their knowledge of the issues addressed in the ICH guideline (Q12) on technical and regulatory issues of medicinal product lifecycle management and the experience of its implementation; the evaluation of generics, the regulation of inhaled medicinal products; extractables and leachables; live biotherapeutic products; approaches to resolving issues related to identified quality defects and market recalls (GMP) and GDP, including, among other things, those that may be foreseen at the pre-registration stage.

The Center expresses sincere gratitude to European Medicines Agency, #TAIEXproject, the European Commission, and the EU Delegation to Ukraine for the invitation to the training and for facilitating the participation of the Ukrainian delegation in this event.